Roferon-A, Interferon alfa-2a recombinant, Sterile Powder for Injection
Social Media Share Tools
- Hoffmann-La Roche
- Roche Laboratories
- Description (Brief)
- Roferon-A is an injectible, recombinant pharmaceutical used to treat different types of leukemia, malignant melanoma, multiple myeloma, non-Hodgkin's lymphoma, AIDS-related sarcoma, and hepatitis. It was discontinued in October 2007, as new therapies for the diseases it treated were developed.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human interferon are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferon, which is harvested and used as the active ingredient in Roferon-A.
- Object consists of a sealed white cardboard box with red and black print.
- Currently not on view
- Credit Line
- Hoffmann-La Roche, Inc.
- ca 1988
- product expiration date
- ID Number
- accession number
- catalog number
- Object Name
- Physical Description
- interferon alfa-2a, recombinant, 18 million iu (drug active ingredients)
- Diluent for Roferon-A, 3 mL (drug active ingredients)
- overall: 2 in x 2 9/16 in x 1 5/16 in; 5.08 cm x 6.50875 cm x 3.33375 cm
- overall: 2 in x 2 1/2 in x 1 3/8 in; 5.08 cm x 6.35 cm x 3.4925 cm
- place made
- United States: New Jersey, Nutley
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Biotechnology and Genetics
- Recombinant Pharmaceuticals
- Science & Mathematics
- Antibody Initiative: Monoclonal Antibodies
- National Museum of American History
- Record ID
- Metadata Usage (text)
- GUID (Link to Original Record)
International media Interoperability Framework
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.